4//SEC Filing
Wendel Bruce 4
Accession 0001654954-21-010887
CIK 0000109657other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 2:47 PM ET
Size
10.8 KB
Accession
0001654954-21-010887
Insider Transaction Report
Form 4
Wendel Bruce
Director
Transactions
- Purchase
Common Stock
2020-11-16$3.14/sh+3,268$10,262→ 3,268 total - Purchase
Common Stock
2020-12-22$8.87/sh+1,374$12,187→ 4,642 total - Award
Option to purchase Common Stock
2021-02-16+50,000→ 50,000 totalExercise: $6.33Exp: 2031-02-15→ Common Stock (50,000 underlying) - Purchase
Common Stock
2020-12-22$8.73/sh+441$3,850→ 5,083 total - Award
Common Stock
2021-02-16+347,572→ 352,655 total
Footnotes (2)
- [F1]Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022.
- [F2]1/3rd of the shares vest on February 16, 2021, 2022, and 2023.
Documents
Issuer
GT Biopharma, Inc.
CIK 0000109657
Entity typeother
Related Parties
1- filerCIK 0001364846
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 2:47 PM ET
- Size
- 10.8 KB